ULTXF yields 20000.00% · MRK yields 2.76%● Live data
📍 ULTXF pulled ahead of the other in Year 1
Combined, ULTXF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ULTXF + MRK for your $10,000?
Ultra Lithium Inc., a mineral exploration company, focuses on the development of advanced lithium and gold projects in Argentina, Canada, and the United States. It holds two types of lithium projects and 16 gold mining and exploration licences. The company focuses on Laguna Verde I Brine lithium property and Laguna Verde II Brine lithium property located in Argentina; and 13 gold mining licenses and three gold exploration licences situated in the Chepes area, Argentina, as well as Georgia Lake Pegmatites lithium project and Forgan Lake Pegmatites lithium project located in Ontario, Canada. The company was formerly known as Ultra Resources Inc. and changed its name to Ultra Lithium Inc. in January 2022. Ultra Lithium Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.
Full ULTXF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.